26 research outputs found
Using Trends in Biometric Data to Predict Interest in Enrolling in an Employer-Sponsored National Diabetes Prevention Program Focusing on Diet and Exercise: A Retrospective Cohort Study
Background: Evidence-based lifestyle programs including the Diabetes Prevention Program can delay an individualâs risk of developing type 2 diabetes. Identifying which individuals are less likely to enroll in these programs and tailoring recruitment approaches to encourage participation among those with perceived barriers is an effective strategy to increase engagement in health promotion. This study aimed to identify the pre-enrollment differences in biometric trends between individuals with prediabetes who did and did not express interest in free worksite diabetes prevention programs.Subjects and Method: This retrospective cohort study was conducted among individuals in the Midwest enrolled in a private insurance plan from 2011 to 2014. Data was combined from annual biometric screenings and a health survey. Demographic characteristics were summarized for the study population (n=2,066). The dependent variable for this study was interest in the DPP, while the independent variables included body mass index, waist circumference, body weight, lipid measurements, and blood pressure. Linear mixed models with random intercepts were used to compare bio-metric trajectories for body mass index, waist circumference, body weight, lipid measurements (triglycerides and cholesterol), and blood pressure for the two groups.Results: No differences were observed in biometric trends for those who did and did not choose to enroll in the free worksite program.Conclusion: Examining pre-enrollment biometric trend data is a relatively novel approach to evaluating engagement in health programs. More research is needed to understand how this information can be used to identify an individualâs interest in enrolling in health programming
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/136447/1/ijc30618-sup-0001-supptables.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/136447/2/ijc30618_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/136447/3/ijc30618.pd
Cancer odds among Ohio firefighters: data from the Ohio Cancer Incidence Surveillance System (OCISS) 1996â2019
Objectives The objective of the current caseâcontrol study was to examine the odds of cancer among firefighters in the state of Ohio and compare the odds of being a firefighter versus police or the general population across different cancer types.Methods Cancer cases were examined from the Ohio Cancer Incidence Surveillance System (OCISS) between 1996 and 2019. Occupation status was classified as firefighter, police or general population. Logistic regression models were run to calculate ORs to determine the odds of being a firefighter compared with police or the general population across different cancer types. Models were adjusted for gender, race, age at cancer diagnosis and year of cancer diagnosis.Results Among the 906â164 cancer cases, 3397 were firefighters and 3341 were police. Firefighters were more likely to be men, white, non-Hispanic, married and a mean age of 66 at the time of cancer diagnosis. Firefighters had increased odds of cancer of the brain (OR=1.40, 95%âCI: 0.99 to 1.99) and thyroid (OR=1.53, 95%âCI: 1.05 to 2.23) compared with police and oesophageal (OR=1.83, 95%âCI: 1.43 to 2.33), skin (OR=1.23, 95%âCI: 1.06 to 1.42), brain (OR=1.37, 95% CI: 1.08 to 1.73) and thyroid (OR=1.52, 95%âCI: 1.18 to 1.96) compared with the general population. They had decreased odds of pancreas, lung and bronchus and bladder compared with both police and the general population. Similar patterns were observed among male firefighters.Conclusions The current study demonstrated increased odds of several different types of cancer among Ohio firefighters compared with other individuals within the OCISS, which may be associated with differences in risk factors, including occupational exposures. The results align with evidence that firefighting is a cancer risk factor. This study is strengthened by the ability to also compare firefighters to police with regards to the odds of cancer. This supports future hypothesis-driven studies examining how specific occupational exposures are associated with increased cancer risk among Ohio firefighters
Identification of myeloid derived suppressor cells in the peripheral blood of tumor bearing dogs
<p>Abstract</p> <p>Background</p> <p>Myeloid derived suppressor cells (MDSCs) are a recently described population of immune cells that significantly contribute to the immunosuppression seen in cancer patients. MDSCs are one of the most important factors that limit the efficacy of cancer immunotherapy (e.g. cancer vaccines) and MDSC levels are increased in cancer in multiple species. Identifying and targeting MDSCs is actively being investigated in the field of human oncology and is increasingly being investigated in veterinary oncology. The treatment of canine cancer not only benefits dogs, but is being used for translational studies evaluating and modifcying candidate therapies for use in humans. Thus, it is necessary to understand the immune alterations seen in canine cancer patients which, to date, have been relatively limited. This study investigates the use of commercially available canine antibodies to detect an immunosuppressive (CD11b<sup>low</sup>/CADO48<sup>low</sup>) cell population that is increased in the peripheral blood of tumor-bearing dogs.</p> <p>Results</p> <p>Commercially available canine antibodies CD11b and CADO48A were used to evaluate white blood cells from the peripheral blood cells of forty healthy control dogs and forty untreated, tumor-bearing dogs. Tumor-bearing dogs had a statistically significant increase in CD11b<sup>low</sup>/CADO48A<sup>low</sup> cells (7.9%) as compared to the control dogs (3.6%). Additionally, sorted CD11b<sup>low</sup>/CADO48A<sup>low</sup> generated <it>in vitro</it> suppressed the proliferation of canine lymphocytes.</p> <p>Conclusions</p> <p>The purpose of this study was aimed at identifying potential canine specific markers for identifying MDSCs in the peripheral blood circulation of dogs. This study demonstrates an increase in a unique CD11b<sup>low</sup>/CADO48A<sup>low</sup> cell population in tumor-bearing dogs. This immunophenotype is consistent with described phenotypes of MDSCs in other species (i.e. mice) and utilizes commercially available canine-specific antibodies. Importantly, CD11b<sup>low</sup>/CADO48A<sup>low</sup> from a tumor environment suppress the proliferation of lymphocytes. These results provide a useful phenotype of cells increased in canine cancer patients that may serve as a useful prognostic marker for assessing immune status and functional response to cancer immunotherapies in dogs. Understanding MDSCs in dogs will allow for increased effectiveness of cancer immunotherapy in both dogs and humans.</p
Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression.
Obesity is an established colon cancer risk factor, while preventing or reversing obesity via a calorie restriction (CR) diet regimen decreases colon cancer risk. Unfortunately, the biological mechanisms underlying these associations are poorly understood, hampering development of mechanism-based approaches for preventing obesity-related colon cancer. We tested the hypotheses that diet-induced obesity (DIO) would increase (and CR would decrease) colon tumorigenesis in the mouse azoxymethane (AOM) model. In addition, we established that changes in inflammatory cytokines, growth factors, and microRNAs are associated with these energy balance-colon cancer links, and thus represent mechanism-based targets for colon cancer prevention. Mice were injected with AOM once a week for 5 weeks and randomized to: 1) control diet; 2) 30% CR diet; or 3) DIO diet. Mice were euthanized at week 5 (nâ=â12/group), 10 (nâ=â12/group), and 20 (nâ=â20/group) after the last AOM injection. Colon tumors were counted, and cytokines, insulin-like growth factor 1 (IGF-1), IGF binding protein 3 (IGFBP-3), adipokines, proliferation, apoptosis, and expression of microRNAs (miRs) were measured. The DIO diet regimen induced an obese phenotype (âŒ36% body fat), while CR induced a lean phenotype (âŒ14% body fat); controls were intermediate (âŒ26% body fat). Relative to controls, DIO increased (and CR decreased) the number of colon tumors (pâ=â0.01), cytokines (p<0.001), IGF-1 (pâ=â0.01), and proliferation (p<0.001). DIO decreased (and CR increased) IGFBP-3 and apoptosis (p<0.001). miRs including mir-425, mir-196, mir-155, mir-150, mir-351, mir-16, let-7, mir34, and mir-138 were differentially expressed between the dietary groups. We conclude that the enhancing effects of DIO and suppressive effects of CR on colon carcinogenesis are associated with alterations in several biological pathways, including inflammation, IGF-1, and microRNAs
Association of Burnout with Workforce-Reducing Factors among EMS Professionals
<p><b>Objectives</b>: Emergency medical services (EMS) professionals often work long hours at multiple jobs and endure frequent exposure to traumatic events. The stressors inherent to the prehospital setting may increase the likelihood of experiencing burnout and lead providers to exit the profession, representing a serious workforce and public health concern. Our objectives were to estimate the prevalence of burnout, identify characteristics associated with experiencing burnout, and quantify its relationship with factors that negatively impact EMS workforce stability, namely sickness absence and turnover intentions. <b>Methods</b>: A random sample of 10,620 emergency medical technicians (EMTs) and 10,540 paramedics was selected from the National EMS Certification database to receive an electronic questionnaire between October, 2015 and November, 2015. Using the validated Copenhagen Burnout Inventory (CBI), we assessed burnout across three dimensions: personal, work-related, and patient-related. We used multivariable logistic regression modeling to identify burnout predictors and quantify the association between burnout and our workforce-related outcomes: reporting ten or more days of work absence due to personal illness in the past 12 months, and intending to leave an EMS job or the profession within the next 12 months. <b>Results</b>: Burnout was more prevalent among paramedics than EMTs (personal: 38.3% vs. 24.9%, work-related: 30.1% vs. 19.1%, and patient-related: 14.4% vs. 5.5%). Variables associated with increased burnout in all dimensions included certification at the paramedic level, having between five and 15Â years of EMS experience, and increased weekly call volume. After adjustment, burnout was associated with over a two-fold increase in odds of reporting ten or more days of sickness absence in the past year. Burnout was associated with greater odds of intending to leave an EMS job (personal OR:2.45, 95% CI:1.95â3.06, work-related OR:3.37, 95% CI:2.67â4.26, patient-related OR: 2.38, 95% CI:1.74â3.26) or the EMS profession (personal OR:2.70, 95% CI:1.94â3.74, work-related OR:3.43, 95% CI:2.47â4.75, patient-related OR:3.69, 95% CI:2.42â5.63). <b>Conclusions</b>: The high estimated prevalence of burnout among EMS professionals represents a significant concern for the physical and mental well-being of this critical healthcare workforce. Further, the strong association between burnout and variables that negatively impact the number of available EMS professionals signals an important workforce concern that warrants further prospective investigation.</p
Real time PCR of microRNAs to validate microarray.
<p>Ten miRs were validated using real-time PCR. They included miR-425, miR-196a, miR-155, miR-150, miR-351, miR-16, let-7f, miR-34c, miR-138a, and miR-21. Results were analyzed using the comparative C<sub>T</sub> method and reported as fold differences compared to the control group. Each bar represents the mean of six animals.</p
Adipokine, IGF-1, IGFBP-3, and insulin levels among CR, control, and DIO mice.
<p>Levels of <b>A</b>) IGF-1, <b>B</b>) IGFBP-3, <b>C</b>) insulin, <b>D</b>) leptin, <b>E</b>) resistin, and <b>F</b>) adiponectin were measured in the serum of the mice ten weeks after the last injection of AOM. Each boxplot represent the mean and range (nâ=â20). Overall differences among groups were determined using a one-way ANOVA. For <b>A</b>) IGF-1, pâ=â0.002; <b>B</b>) IGFBP-3, p<0.001; <b>C</b>) insulin, pâ=â0.002; <b>D</b>) leptin, p<0.0001; <b>E</b>) resistin, pâ=â0.001; and <b>F</b>) adiponectin, pâ=â0.14. <i>a</i>,<i>b</i>, and <i>c</i> represent dietary treatments that are significantly different (p<0.05) from one another as determined by a Bonferroni test.</p
A. Bodyweights in calorie restricted (CR), control, and diet-induced obesity (DIO) FVB mice.
<p>Bodyweight was measured weekly in all three dietary interventions. Each data point represents the mean of all the mice in that dietary group. B. Body fat in CR, control, and DIO dietary treatments. Dual-energy X-ray absorptiometer (DEXA) scans were conducted at the beginning of the study and after ten weeks of dietary treatment. Each bar represents the mean of ten mice per group. One-way analysis of variance (ANOVA) at the beginning of the study, pâ=â0.78. One-way ANOVA at ten weeks, p<0.001. <i>a</i>, <i>b</i>, and <i>c</i> represent dietary treatments that are significantly different from one another (p<0.05) as determined by Bonferroni test.</p